Searched for
AI IN DRUG APPROVAL
Claude Fable 5 & Mythos 5: Key highlights from Anthropic’s latest launchAnthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...- Neeraj Sharma case: How fake job offers triggered major H-1B visa fraud probe in the USUS H1-B visa fraud: A major US immigration fraud probe targets 17 naturalised citizens. Neeraj Sharma, an Indian-origin CEO, faces denatura...
- AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- India losing investor attention to Asia’s AI-electronics surge, says DBS economistGlobal capital is shifting towards electronics and AI in Asia. India's foreign direct investment slowdown is not a major concern. Asia's ex...
- Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...
- US stocks today: US market slips on Middle East impasse, mixed earningsU.S. stock indexes opened lower on Thursday as investors remained cautious amid uncertainty surrounding the U.S.-Iran conflict. Mixed corpo...
- Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
- Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
- Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...
- IIT Bombay's new smart platform to help researchers decode brain diseasesIIT Bombay bioengineers have created new smart platforms. BrainProt unifies brain disease data from genes to proteins. DrugProtAI predicts ...
- OpenAI backs startup aiming to block AI-enabled bio weaponsOpenAI is the lead investor in a $15 million seed round in Red Queen Bio, which is trying to make sure the AI industry's defenses are growi...
- From pharmacy to innovation hub: Why India needs a regulatory revolution in biotechIndia aims to transition from a global pharmacy to an innovation hub by reforming its regulatory landscape. The focus is on AI-powered appr...
- Cancer treatment: Ray of hope is finally here? Check detailsThe US University researchers have claimed that they found an effective way to detect cancer.
- AI startup Unlearn raises $15 million in funding, adds OpenAI CTO Mira Murati to boardMira Murati, chief technology officer at Microsoft-backed OpenAI, is joining the startup's board.
- IIT Roorkee scientists predict FDA-approved commercial drugs through AI to tackle COVID-19Amid the rapid transmission of cases of Covid-19, a group of scientists from IIT Roorkee has leveraged Artificial Intelligence (AI) to pred...
- Tech Mahindra R&D unit leverages AI for research on potential therapeutic drugs for COVID-19Tech Mahindra's Makers Lab aims to promote technology innovation and recognize transformative ideas that have a potential to make a differe...
- AI technique used to treat metastatic cancer patient: StudySingapore, Sep 2 (IANS) Singaporean researchers have harnessed the power of artificial intelligence (AI) to successfully treat a patient wi...
Load More
